Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Compumedics Limited

Market Cap 48.94M 34.23M 29.71M 27.38M 25.66M 47.94M 3.28B 327M 126M 1.58B 129M 126M 5.49B P/E Ratio 2026 *
16.3x
P/E Ratio 2027 * 6.62x
Enterprise Value 48.94M 34.23M 29.71M 27.38M 25.66M 47.94M 3.28B 327M 126M 1.58B 129M 126M 5.49B EV / Sales 2026 *
0.74x
EV / Sales 2027 * 0.61x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.16%
1 day-2.04%
1 week-4.00%
Current month-11.11%
1 month-17.24%
3 months-25.00%
6 months-30.43%
Current year-28.36%
1 week 0.24
Extreme 0.24
0.26
1 month 0.24
Extreme 0.24
0.28
Current year 0.24
Extreme 0.24
0.45
1 year 0.24
Extreme 0.24
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 2010-12-15
Director of Finance/CFO 61 2009-11-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 2010-12-15
Director/Board Member 61 1999-12-31
Director/Board Member - 2022-10-26
Change 5-day change 1-year change 3-year change Capi.($)
-2.04%-4.00%-12.73%+20.00% 34.23M
-1.32%-1.32%+14.58%-8.21% 177B
+0.21%-1.41%-20.96%+32.02% 146B
-1.55%-3.13%-11.69%-23.19% 128B
-2.42%-3.44%-52.55%-8.01% 70.11B
-0.26%-1.93%+13.63%+1.97% 49.38B
+1.26%+0.17%-24.80%-33.80% 44.23B
-1.57%-6.37%+8.21%+11.88% 36.59B
-0.95%-4.44%+3.96%+44.31% 35.32B
+1.18%+1.10%-12.11%-16.33% 29.35B
Average -0.40%-2.34%-9.45%+2.06% 71.6B
Weighted average by Cap. -0.48%-2.08%-8.39%-0.24%

Financials

2026 *2027 *
Net sales 66.3M 46.38M 40.25M 37.1M 34.76M 64.95M 4.44B 443M 171M 2.14B 174M 170M 7.44B 79.7M 55.75M 48.38M 44.6M 41.79M 78.07M 5.34B 532M 206M 2.57B 209M 205M 8.95B
Net income 3.8M 2.66M 2.31M 2.13M 1.99M 3.72M 255M 25.36M 9.82M 123M 9.98M 9.76M 427M 9M 6.3M 5.46M 5.04M 4.72M 8.82M 603M 60.07M 23.26M 291M 23.63M 23.12M 1.01B
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
26-06-12 0.2400 $ -2.04% 46,493
26-06-11 0.2450 $ -2.00% 47,976
26-06-10 0.2500 $ 0.00% 43,562
26-06-09 0.2500 $ -1.96% 17,161
26-06-04 0.2550 $ -3.77% 49,820
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2450AUD
Average target price
0.8000AUD
Spread / Average Target
+226.53%

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!